Prolonged Exposition with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) May Provide Survival Benefit after Cytoreductive Surgery (CRS) in Advanced Primary Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

Prolonged Exposition with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) May Provide Survival Benefit after Cytoreductive Surgery (CRS) in Advanced Primary Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

Background: The usage of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced gynecological cancers is increasing. Methods: Prospectively collected data of 85 advanced primary ovarian/fallopian tube cancer and peritoneal carcinoma patients of a single ce...

Full description

Bibliographic Details
Main Authors: Miklos Acs, Zoltan Herold, Attila Marcell Szasz, Max Mayr, Sebastian Häusler, Pompiliu Piso
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Cancers
Subjects:
ovarian cancer
peritoneal carcinomatosis
cytoreductive surgery
HIPEC
HIPEC duration
Online Access:https://www.mdpi.com/2072-6694/14/14/3301

Internet

https://www.mdpi.com/2072-6694/14/14/3301

Similar Items